Response to saluretics and oral antidiabetics in diabetes insipidus and psychic polydipsia.
D000293:Adolescent; D000328:Adult; D002740:Chlorothiazide / Q000627:therapeutic use*; D002747:Chlorpropamide / Q000627:therapeutic use*; D003404:Creatinine / Q000652:urine; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000652:urine; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000652:urine; D011602:Psychophysiologic Disorders; D012964:Sodium / Q000652:urine; D013046:Specific Gravity; D013148:Spironolactone / Q000627:therapeutic use*; D013894:Thirst; D013997:Time Factors; D014867:Water / Q000378:metabolism; D014882:Water-Electrolyte Balance
D014867:Water; D013148:Spironolactone; D002740:Chlorothiazide; D012964:Sodium; D003404:Creatinine; D011188:Potassium; D002747:Chlorpropamide